Twin Tree Management, LP Astrazeneca PLC Transaction History
Twin Tree Management, LP
- $51.8 Billion
- Q2 2025
A detailed history of Twin Tree Management, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Twin Tree Management, LP holds 484,300 shares of AZN stock, worth $41 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
484,300
Previous 661,500
26.79%
Holding current value
$41 Million
Previous $48.6 Million
30.39%
% of portfolio
0.07%
Previous 0.09%
Shares
25 transactions
Others Institutions Holding AZN
# of Institutions
1,459Shares Held
490MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.39 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.48 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.9 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.66 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.64 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $262B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...